Jessica Siminski
Family · Owosso, MINPI 1750773461
Payments from drug & device makers
Across 106 payments — averaging $16.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$411
- AbbVie$240
- GSK$142
- Pfizer$139
- AstraZeneca$133
- Boehringer Ingelheim$97
- plus $605 from 16 others
What the payments were for
- Food & beverage$1,767100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 23 | $411 |
| AbbVie | 18 | $240 |
| GSK | 9 | $142 |
| Pfizer | 8 | $139 |
| AstraZeneca | 9 | $133 |
| Boehringer Ingelheim | 5 | $97 |
| Astellas Pharma US Inc | 4 | $84 |
| Lilly USA, LLC | 4 | $62 |
| Novartis | 3 | $50 |
| Actelion Pharmaceuticals US, Inc. | 2 | $47 |
| Merck | 3 | $43 |
| Bayer | 2 | $41 |
| Sanofi Pasteur Inc. | 2 | $40 |
| Amarin Pharma, Inc. | 3 | $40 |
| Aimmune Therapeutics, Inc. | 2 | $39 |
| Dexcom, Inc. | 2 | $35 |
| Amgen | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $19 |
| Edwards Lifesciences | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $14 |
How this compares
$1,767 in reported general payments places this provider in the 80th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 24 | $31,816 |
| OzempicSemaglutide | 23 | $26,376 |
| JardianceEmpagliflozin | 15 | $17,388 |
| TradjentaLinagliptin | 11 | $9,691 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $2,041 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 34 | $1,400 |
| Levothyroxine Sodium | 109 | $1,231 |
| Atorvastatin Calcium | 77 | $1,173 |
| Omeprazole | 82 | $1,033 |
| Potassium Chloride | 20 | $884 |
| Gabapentin | 29 | $860 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 13 | $850 |
| Rosuvastatin Calcium | 44 | $812 |
| Losartan Potassium | 42 | $793 |
| Duloxetine Hcl | 25 | $777 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $139 | $31,81624 claims |
| Boehringer IngelheimJardiance, Tradjenta | $97 | $27,07926 claims |
| Novo NordiskOzempic | $411 | $26,37623 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $19 | $1,231109 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,657 family providers in Michigan.
Other family in Owosso
- Kylie KattelusOwosso$18K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.